Loading...
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 3rd–5th, 2020, Italy)
Advances in immune checkpoint therapy and targeted therapy have led to improvement in overall survival for patients with advanced melanoma. Single agent checkpoint PD-1 blockade and combination with BRAF/MEK targeted therapy demonstrated benefit in overall survival (OS). Superior response rates have...
Na minha lista:
| Udgivet i: | J Transl Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8243582/ https://ncbi.nlm.nih.gov/pubmed/34193182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-021-02951-x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|